IRP_USA_ALS Blog Post Image

How the Latest Developments Will Change your Business Strategy

By Davide Zaganelli, Global Emerging Markets Manager


With expectations to reach 30% of the nearly $1.2 trillion US global spend, and 50-70% of the $70 billion annual US growth forecasted in the pharmaceutical sector by 2016, it is clear why emerging markets are considered the new frontier. They are the new hope for a pharmaceutical industry that is seeking new strategies and partnerships to balance the stagnation in more mature markets…